Cross-source evidence timeline

Efinopegdutide research timeline

Follow 10 selected, directly cited source records from April 16, 2019 through November 9, 2026. This timeline joins source lanes for navigation; it does not infer that one record confirms another.

10Selected records
4Source years
2Evidence lanes
November 9, 2026Latest source date

Source year

2026

3 records
  1. Literature metadata

    Efinopegdutide: a step towards precision in MASH therapy?↗

    PubMed lists PMID 43003104 in Lancet (London, England) as Journal Article, with publication-date metadata of 2026-11-09 (day precision). PeptideScanner associated the retained record with the identity slug efinopegdutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  2. Clinical trials

    ClinicalTrials.gov record NCT06465186↗

    PeptideScanner retained ClinicalTrials.gov record NCT06465186 at 2026-11-16T17:46:45.897Z. Its registry update date was 2026-09-21, and PeptideScanner's reviewed identity mapping was efinopegdutide.↗

  3. Clinical trials

    ClinicalTrials.gov record NCT06482112↗

    PeptideScanner retained ClinicalTrials.gov record NCT06482112 at 2026-11-16T17:46:45.897Z. Its registry update date was 2026-06-01, and PeptideScanner's reviewed identity mapping was efinopegdutide.↗

Source year

2025

5 records
  1. Clinical trials

    ClinicalTrials.gov record NCT06052566↗

    PeptideScanner retained ClinicalTrials.gov record NCT06052566 at 2026-11-16T17:46:45.897Z. Its registry update date was 2025-10-22, and PeptideScanner's reviewed identity mapping was efinopegdutide.↗

  2. Clinical trials

    ClinicalTrials.gov record NCT03235219↗

    PeptideScanner retained ClinicalTrials.gov record NCT03235219 at 2026-11-16T17:46:45.897Z. Its registry update date was 2025-04-27, and PeptideScanner's reviewed identity mapping was efinopegdutide.↗

  3. Clinical trials

    ClinicalTrials.gov record NCT03546205↗

    PeptideScanner retained ClinicalTrials.gov record NCT03546205 at 2026-11-16T17:46:45.897Z. Its registry update date was 2025-04-27, and PeptideScanner's reviewed identity mapping was efinopegdutide.↗

  4. Clinical trials

    ClinicalTrials.gov record NCT06701305↗

    PeptideScanner retained ClinicalTrials.gov record NCT06701305 at 2026-11-16T17:46:45.897Z. Its registry update date was 2025-02-26, and PeptideScanner's reviewed identity mapping was efinopegdutide.↗

  5. Clinical trials

    ClinicalTrials.gov record NCT06836037↗

    PeptideScanner retained ClinicalTrials.gov record NCT06836037 at 2026-11-16T17:46:45.897Z. Its registry update date was 2025-02-21, and PeptideScanner's reviewed identity mapping was efinopegdutide.↗

Source year

2020

1 record
  1. Clinical trials

    ClinicalTrials.gov record NCT03606057↗

    PeptideScanner retained ClinicalTrials.gov record NCT03606057 at 2026-11-16T17:46:45.897Z. Its registry update date was 2020-03-03, and PeptideScanner's reviewed identity mapping was efinopegdutide.↗

Source year

2019

1 record
  1. Clinical trials

    ClinicalTrials.gov record NCT03586843↗

    PeptideScanner retained ClinicalTrials.gov record NCT03586843 at 2026-11-16T17:46:45.897Z. Its registry update date was 2019-04-16, and PeptideScanner's reviewed identity mapping was efinopegdutide.↗